RNS Number : 8666B MaxCyte, Inc. 15 June 2021 MaxCyte Adds Two New Non-Executive Directors to Its Board Gaithersburg, Maryland - 15 June 2021 : MaxCyte (LSE: MXCT, MXCN), a leading provider of platform technologies for cell engineering, today announced the appointment of Rekha Hemrajani
RNS Number : 6449Z MaxCyte, Inc. 25 May 2021 FOR IMMEDIATE RELEASE Celularity and MaxCyte Sign Strategic Platform Licence to Advance Celularity's Off-the-shelf Allogeneic Cellular Therapy Product Candidates Celularity to utilize MaxCyte's Flow Electroporation ® technology and ExPERT ™
Released : February 23, 2021 07:00 RNS Number : 9618P MaxCyte, Inc. 22 February 2021 FOR IMMEDIATE RELEASE MaxCyte to Participate in Two Upcoming Virtual Healthcare Investor Conferences GAITHERSBURG, MD , February 23, 2021 - MaxCyte, Inc., a global cell-based
Myeloid to utilize MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to advance its novel cell therapies to treat solid tumors, T cell lymphoma and glioblastoma CAMBRIDGE, MA and GAITHERSBURG, MD, January 11, 2021 — Myeloid Therapeutics, Inc., a company harnessing and reprogramming
Released : January 11, 2021 07:00 RNS Number : 1564L MaxCyte, Inc. 11 January 2021 Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid's Cell Therapy Programs Myeloid to utilize MaxCyte's Flow Electroporation ® technology and ExPERT ™
Released : November 09, 2020 13:00 RNS Number : 6703E MaxCyte, Inc. 09 November 2020 CARMA Cell Therapies™ to Share Results of In-vitro Characterization of MCY-M11 at SITC 2020 Annual Meeting Gaithersburg, Maryland - 9 November 2020: MaxCyte, Inc.
Released : November 09, 2020 07:00 RNS Number : 5929E MaxCyte, Inc. 09 November 2020 MaxCyte to Present at Two Upcoming Virtual Healthcare Investor Conferences Gaithersburg, MD , 9 November 2020: MaxCyte, Inc. (LSE: MXCT, MXCL), a global cell-based therapies and life sciences
Released : October 13, 2020 07:00 RNS Number : 8523B MaxCyte, Inc. 13 October 2020 MaxCyte Bolsters Leadership Team with Promotion of Brad Calvin to Chief Commercial Officer and New Key VP Appointments Gaithersburg, Maryland - 13 October 2020: MaxCyte, Inc.
Released : September 10, 2020 07:00 RNS Number : 5403Y MaxCyte, Inc. 10 September 2020 MaxCyte to Present at Upcoming 2020 H.C. Wainright & Co 22nd Annual Global Investment Virtual Conference GAITHERSBURG, MD , 10 September 2020 - MaxCyte, Inc.
Released : September 09, 2020 07:00 RNS Number : 3947Y MaxCyte, Inc. 09 September 2020 MaxCyte Appoints Amanda L. Murphy as Chief Financial Officer and Names Ron Holtz as Senior Vice President & Chief Accounting Officer - Murphy brings a wealth of life sciences capital markets
